Efficacy of traditional Chinese medicine combined with Renvatinib and Camrelizumab in managing stage IIB primary hepatocellular carcinoma with hepatitis B and compensated cirrhosis

Gelijkaardige items

• Hepatic Arterial Infusion Chemotherapy Combined Apatinib/Camrelizumab for Recurrent Hepatocellular Carcinoma After Hepatectomy
  door: Zheng X, et al.
  Gepubliceerd in: (2025-06-01)
• Use of camrelizumab in treatment of nasopharyngeal carcinoma
  door: Yu. V. Alymov, et al.
  Gepubliceerd in: (2024-12-01)
• Efficacy and Safety of Hepatic Artery Infusion Chemotherapy Combined with Donafenib and Camrelizumab in the Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Retrospective, Single-Arm Study
  door: Wu C, et al.
  Gepubliceerd in: (2025-07-01)
• Cirrhosis of the liver and hepatocellular carcinoma in the outcome of chronic hepatitis C: a case report
  door: V. V. Makashova, et al.
  Gepubliceerd in: (2023-04-01)
• A Health Economic Evaluation of Routine Hepatocellular Carcinoma Surveillance for People with Compensated Cirrhosis to Support Australian Clinical Guidelines
  door: Joachim Worthington, et al.
  Gepubliceerd in: (2025-06-01)